# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Liliʻuokalani (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET024-SYN-TD
- Date: 1917-03-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Kealani Morrison-Takeda, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Stroke clinic the morning after the emergency evaluation. **S**

## History of present illness

Liliʻuokalani is seen the morning after her emergency evaluation, with two members of her ʻohana whom she asked to come, and is seen the same day by Dr. Abernethy-Sato of vascular neurology. The episode two days ago, about 20 minutes of right hand weakness and difficulty finding words while she was playing the piano, has not recurred. In the emergency department yesterday the CT showed no bleeding, the CT angiogram showed no blocked vessel and a calcified plaque narrowing the left internal carotid artery by less than 50%, and she passed the bedside swallow screen; she was given aspirin 325 mg and clopidogrel 300 mg about 18 hours after the symptoms began and went home. This morning's MRI shows a small new infarct in the left precentral cortex, so the episode was a minor stroke, not a transient ischemic attack. The echocardiogram shows normal pumping, a mildly enlarged left atrium and no clot. She has had no palpitations. She asks plainly what has happened, and wants her ʻohana to understand it too. **S**

| Element | Detail |
|---|---|
| Emergency evaluation | CT: no hemorrhage. CT angiography: no occlusion; left internal carotid plaque under 50%. Swallow screen passed |
| MRI | 8 mm acute infarct, left precentral cortex |
| Echocardiogram | Ejection fraction 60%; left atrium mildly enlarged; no thrombus |
| Antiplatelets | Aspirin and clopidogrel loaded about 18 hours after onset |
| Cognition | MoCA 26 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Negative | No new weakness, numbness, speech, vision or balance problem since the episode |
| Cardiovascular | Negative | No palpitations, chest pain or fainting |
| Hematologic | Negative | No bruising or bleeding on two antiplatelets |
| Psychiatric | Positive | Worried about another episode; PHQ-2 score 1 |

4 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release oral tablet, one tablet daily for 21 days, after a 325 mg loading dose in the emergency department **S**
- Clopidogrel 75 mg oral tablet, one tablet daily, after a 300 mg loading dose in the emergency department **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 148/86 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 58 kg; BMI 22.7 kg/m². All vital signs are synthetic.

NIH Stroke Scale: 0; LVEF by echocardiogram: 60%; Left atrial volume index: 37 mL/m² (high); MoCA: 26; PHQ-2: 1. All results are synthetic.

## Change since baseline

- NIH Stroke Scale: 0 at baseline, 0 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert and composed; blood pressure 148/86, pulse 70 and regular |
| Neurological | NIH Stroke Scale 0; speech fluent with normal naming and repetition; no drift; normal grip and rapid finger movements of both hands; normal gait |
| Neck | No carotid bruit |
| Cardiovascular | Regular rhythm; no murmur |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Minor ischemic stroke, left precentral cortex** (I63.412). Diffusion MRI shows that the 20-minute episode was a minor stroke. Its cortical, embolic pattern raises the question of atrial fibrillation; the carotid plaque narrows the artery by less than 50% and is a less likely source. Dr. Abernethy-Sato agrees with the plan. **S**
   - Aspirin 81 mg and clopidogrel 75 mg daily for 21 days in all, then clopidogrel alone.
   - 30-day ambulatory rhythm monitor applied today.
   - Atorvastatin 40 mg daily; lipid panel in four to twelve weeks.
   - BE FAST taught to her and her ʻohana.
2. **Hypertension** (I10). 148/86 mmHg the day after the event; treatment is best begun a few days after a stroke. **S**
   - Home readings twice daily for a week; if the average is 130/80 or higher, start losartan 25 mg daily, with potassium and creatinine two weeks later.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic and at home (target below 130/80 mmHg) and weight | Every visit | Completed today | 148/86 mmHg; 58.0 kg; home monitor provided |
| Medication safety | Antithrombotic therapy and adherence | Every visit | Completed today | Day 2 of 21 days of aspirin and clopidogrel; no bleeding |
| Examination | Neurological status (NIH Stroke Scale at the event; modified Rankin Scale at 90 days) and new symptoms | At the event and with any change; modified Rankin Scale at 90 days | Completed today | NIH Stroke Scale 0 in the emergency department and today |
| Imaging | Brain MRI with diffusion | At the event | Completed today | 8 mm acute infarct in the left precentral cortex |
| Imaging | Carotid and intracranial vessel imaging | At the event; follow-up only for treated or moderate or greater stenosis | Completed today | CT angiography in the emergency department: left internal carotid plaque under 50%; no intracranial stenosis |
| Imaging | Echocardiogram | At the event | Completed today | Ejection fraction 60%; left atrial volume index 37 mL/m2; no thrombus |
| Imaging | ECG and prolonged rhythm monitoring for atrial fibrillation | ECG at baseline; at least 30 days of monitoring within six months of the event | Ordered | ECG at intake: sinus rhythm. 30-day patch monitor applied today |
| Laboratory | Lipid panel (LDL goal below 70 mg/dL) | Four to twelve weeks after starting a statin, then every three to twelve months | Ordered | LDL 132 mg/dL at intake; atorvastatin 40 mg started; panel due in four to twelve weeks |
| Laboratory | Diabetes screen (hemoglobin A1c) | At the event, then periodically | Up to date | 5.5% at intake |
| Survey | Cognitive screen (MoCA) | After the event, again within the first year, then periodically | Completed today | MoCA 26 |
| Survey | Depression screen (PHQ-2, PHQ-9) | At the first post-stroke visit, then at least yearly | Completed today | PHQ-2 1; PHQ-9 planned at the three-month review |
| Examination | Swallow screen | Before any food or drink after a stroke | Up to date | Bedside swallow screen passed in the emergency department; eating normally |
| Examination | Falls risk | Every visit | Completed today | No falls; steady gait |
| Self-management | Tobacco, alcohol and physical activity | Every visit | Completed today | Never smoker; alcohol rarely; walks daily |
| Self-management | BE FAST and calling 911 | Every visit | Completed today | Taught to her and two members of her ʻohana |
| Self-management | Culturally safe care: her choices, ʻohana involvement and Native Hawaiian healing alongside clinic care | Every visit | Completed today | She leads the decisions with her ʻohana present; lomilomi and hoʻoponopono offered alongside clinic care; nothing further asked |
| Referral | Vascular neurology consultation | At the event | Completed today | Seen by Dr. Abernethy-Sato today |

## Goal progress

- No recurrent stroke or transient ischemic attack. In progress; target 1917-08-24. **S**
- LDL cholesterol below 70 mg/dL. In progress; target 1917-04-20. **S**
- Blood pressure below 130/80 mmHg at home and in the clinic. In progress; target 1917-06-15. **S**
- Anticoagulation that is safe and taken as prescribed, without major bleeding. In progress; target 1917-08-24. **S**
- Keep playing the piano and composing. In progress; target 1917-06-15. **S**

## Guideline basis

- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association (Stroke 2021;52(7):e364-e467)
- Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association (Stroke 2021;52(9):e558-e571)
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) (2018), New England Journal of Medicine 2018;379(3):215-225
- Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) (2013), New England Journal of Medicine 2013;369(1):11-19
- 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke (2024), American College of Cardiology (J Am Coll Cardiol 2025;85(6):657-681)
- CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, atrial fibrillation and hypertension monographs (2026), Aether Forge
- Signs and Symptoms of Stroke (2026), Centers for Disease Control and Prevention
- Ke Ola Mamo: a Native Hawaiian Health Care System serving Oʻahu (medical care, lomilomi and community health workers) (2026), Ke Ola Mamo

## Follow-up

- Five-week review when the monitor result is ready. Call 911 for any BE FAST sign, even if it passes. Call for bleeding or black stools. **S**
- Next scheduled visit 1917-04-20: five-week review: rhythm monitor result, anticoagulation decision, lipids, kidney function and blood pressure. **S**
